By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Newron Pharmaceuticals 

Via R. Lepetit
Gerenzano      Italy
Phone: 39-02-9668131 Fax: 39-02-96681333



Company News
Newron Pharma (NWRN) Supports Rett Syndrome Awareness Month 10/24/2016 8:42:53 AM
U.S. FDA Considers Newron Pharma (NWRN)'s Re-Submitted NDA For Xadago To Be A Complete, Class 2 Response To Complete Response Letter 10/21/2016 11:11:55 AM
Newron Pharma (NWRN) Re-submits U.S. NDA For Xadago (Safinamide) 9/22/2016 10:44:52 AM
Newron Pharma (NWRN) Reports Half-Year 2016 Results 9/15/2016 11:35:22 AM
Newron Pharma (NWRN) To Re-Submit U.S. NDA For Xadago (Safinamide) 7/26/2016 10:28:19 AM
Newron Pharma (NWRN) Announces Initiation Of The STARS Study In The United States 7/21/2016 9:41:49 AM
Newron Pharma (NWRN) To Evaluate Burden Of Disease For Rett Syndrome Patients And Families 6/27/2016 11:02:31 AM
Newron Pharma (NWRN) To Present STARS Trial Design At U.S. Rett Syndrome Symposium 6/16/2016 7:53:30 AM
Newron Pharma (NWRN) To Present At The Jefferies 2016 Healthcare Conference In New York 5/25/2016 10:52:20 AM
Newron Pharma (NWRN) Announces IND Approval For Sarizotan For Treatment Of Rett Syndrome 5/17/2016 11:29:50 AM